NVIDIA
NVDA
MARA Holdings
MARA
Meta Platforms
META
Oracle
ORCL
Coinbase
COIN
US Stock MarketDetailed Quotes
XFOR X4 Pharmaceuticals
- 0.441
- +0.005+1.12%
Trading Feb 26 10:03 ET
75.23MMarket Cap-5.51P/E (TTM)
0.446High0.430Low144.45KVolume0.434Open0.436Pre Close63.27KTurnover0.11%Turnover RatioLossP/E (Static)170.55MShares1.60052wk High1.26P/B56.56MFloat Cap0.26152wk Low--Dividend TTM128.24MShs Float23.930Historical High--Div YieldTTM3.55%Amplitude0.261Historical Low0.438Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
X4 Pharmaceuticals Stock Forum
X4 Pharmaceuticals (XFOR) and taiba rare, a healthcare company, announced a strategic exclusive partnership for the distribution and commercialization of XOLREMDI in select Middle East countries, pending regulatory approvals.
5 mins ago
X4 Pharmaceuticals and Taiba Rare Announce Exclusive Agreement for the Distribution and Commercialization of Xolremdi® (Mavorixafor) in Whim Syndrome in Select Middle East Countries
Groundbreaking WHIM Syndrome Drug Enters Middle East: Inside X4's Strategic Distribution Deal
how much downsizing is 30%?
No comment yet